HLS Therapeutics Inc
OTC:HLTRF
HLS Therapeutics Inc
OTC:HLTRF
Price:
3
USD
Market Cap:
$95.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
HLS Therapeutics Inc
OTC:HLTRF
|
CA |
|
Transcoal Pacific Tbk PT
IDX:TCPI
|
ID |
|
Cita Mineral Investindo Tbk PT
IDX:CITA
|
ID |
|
WuXi AppTec Co Ltd
SSE:603259
|
CN |
|
YPF SA
NYSE:YPF
|
AR |
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
US |
|
I
|
Inmobiliaria Park Rose Iberoamericana SOCIMI SA
MAD:YPARK
|
ES |
|
S
|
SCB X PCL
SET:SCB
|
TH |
|
Union Technologies Informatique Group SA
PAR:FPG
|
FR |
|
Voltalia SA
PAR:VLTSA
|
FR |
|
P
|
Phoenix Holdings Ltd
TASE:PHOE
|
IL |
|
F
|
Fosun Tourism Group
HKEX:1992
|
CN |
|
Victoria Oil & Gas PLC
LSE:VOG
|
UK |
|
BGR Energy Systems Ltd
NSE:BGRENERGY
|
IN |
Multiples-Based Value
The
Multiples-Based Value for
HLS Therapeutics Inc (HLTRF)
under the Base Case is
hidden
USD.
Compared with the current market price of 3 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HLTRF Multiples-Based Value
LOCKED
Multiples Across Competitors
HLTRF Competitors Multiples
HLS Therapeutics Inc Competitors
HLS Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
HLS Therapeutics Inc
OTC:HLTRF
|
136.7m USD | 1.8 | -8 | 8.1 | -24.2 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
105.8B USD | 0.3 | 24.5 | 17.3 | 19.4 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.7B USD | 0.2 | 37.3 | 13.2 | 16.7 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.3B USD | 0.2 | 37.6 | 13.3 | 16.9 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
48.7B USD | 0.2 | 30 | 14.5 | 18.9 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.6B AUD | 2.7 | 33.8 | 25.1 | 25.1 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
62.4B CNY | 1.4 | 16.8 | 13 | 13 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.3B CNY | 0.2 | 11 | 15 | 15 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.4B USD | 0.6 | 21.4 | 10.4 | 14.7 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
63.7B HKD | 0.1 | 8 | 0.7 | 0.8 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
